Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)DivestmentsFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BridgeBio Pharma (BBIO) Amortizatization of Intangibles (2019 - 2025)

Historic Amortizatization of Intangibles for BridgeBio Pharma (BBIO) over the last 7 years, with Q3 2025 value amounting to -$49.7 million.

  • BridgeBio Pharma's Amortizatization of Intangibles fell 870549.65% to -$49.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.1 million, marking a year-over-year increase of 20341.38%. This contributed to the annual value of $15.8 million for FY2024, which is 7697.32% up from last year.
  • BridgeBio Pharma's Amortizatization of Intangibles amounted to -$49.7 million in Q3 2025, which was down 870549.65% from $27.5 million recorded in Q2 2025.
  • In the past 5 years, BridgeBio Pharma's Amortizatization of Intangibles registered a high of $27.5 million during Q2 2025, and its lowest value of -$49.7 million during Q3 2025.
  • Moreover, its 5-year median value for Amortizatization of Intangibles was $2.1 million (2022), whereas its average is $2.2 million.
  • Within the past 5 years, the most significant YoY rise in BridgeBio Pharma's Amortizatization of Intangibles was 154658.27% (2025), while the steepest drop was 870549.65% (2025).
  • BridgeBio Pharma's Amortizatization of Intangibles (Quarter) stood at $1.8 million in 2021, then increased by 19.92% to $2.1 million in 2022, then grew by 3.9% to $2.2 million in 2023, then soared by 479.2% to $12.6 million in 2024, then tumbled by 492.78% to -$49.7 million in 2025.
  • Its Amortizatization of Intangibles stands at -$49.7 million for Q3 2025, versus $27.5 million for Q2 2025 and $25.6 million for Q1 2025.